Postmortem analysis of HFD‐fed ANGPTL2‐deficient mice revealed reduced tumor development, which is consistent with our previous findings that ANGPTL2 signaling in tumor cells promotes tumor progression (Horiguchi et al. 2014, 2022). The gene discussed is ANGPTL2; the disease is neoplasm.